Diagnosis, prevention and management of ovarian hyperstimulation syndrome

British Journal of Obstetrics and Gynaecology
P R BrinsdenH S Jacobs

Abstract

The overall incidence of clinically important (moderate to severe) OHSS ranges from 1% to 10% of IVF cycles, but only a small proportion (0.5% to 2%) of the cases are severe. In extreme but rare cases, secondary complications such as deep vein thrombosis, respiratory distress and acute hepato-renal failure may occur. The main risk factors are the presence of polycystic ovaries, high ovarian response to superovulation therapy, the use of hCG to trigger the ovulatory process or for luteal phase support, and the endogenous production of hCG by an early pregnancy. The pathogenesis of OHSS is unknown, although the predominant biochemical mediator is thought to be the renin-angiotensin system. Ovarian stimulation should always be carefully monitored to identify those women at risk. In IVF cycles, the hCG injection should be withheld if the risk is judged to be too great. Some women will benefit from a policy of proceeding to collect oocytes, but electively cryopreserving any resulting embryos, thus allowing the ovarian stimulation cycle not to be wasted. The administration of albumin at the time of oocyte collection will reduce the chance of severe OHSS occurring. If a decision is made to proceed with oocyte recovery and embryo trans...Continue Reading

References

Sep 1, 1978·Fertility and Sterility·J G Schenker, D Weinstein
Oct 1, 1992·Journal of Assisted Reproduction and Genetics·P A Bergh, D Navot
Jul 11, 1992·Human Reproduction·N McClureR V Haning
Jun 1, 1992·Journal of Assisted Reproduction and Genetics·M A AboulgharY Amin
May 1, 1992·Human Reproduction·M J MacDougallH S Jacobs
Jan 1, 1991·Fertility and Sterility·N N AmsoN Morris
Jan 1, 1990·Human Reproduction·J Salat-BarouxJ Mandelbaum
Aug 1, 1990·Human Reproduction·B RizkA M Fisher
Jan 1, 1990·Fertility and Sterility·S MashiachZ Ben-Rafael
Jun 1, 1989·Obstetrical & Gynecological Survey·A GolanE Caspi
Mar 1, 1987·Fertility and Sterility·A ZosmerZ Schwartz-Shoham
May 1, 1967·American Journal of Obstetrics and Gynecology·E RabauB Lunenfeld
Apr 1, 1993·British Journal of Obstetrics and Gynaecology·I WadaB A Lieberman

❮ Previous
Next ❯

Citations

Feb 15, 2002·Human Fertility : Journal of the British Fertility Society·Rina Agrawal
Oct 10, 2001·Human Fertility : Journal of the British Fertility Society·S F Marcus, W L Ledger
Sep 10, 2003·Human Fertility : Journal of the British Fertility Society·Peter SchwärzlerHanns-Kristian Rjosk
Oct 30, 2004·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·R K Bhathena
Mar 6, 2012·Reproductive Biomedicine Online·Basil C TarlatzisBernadette M J L Mannaerts
Dec 3, 2011·Reproductive Biomedicine Online·Jyotsna PundirYacoub Khalaf
Jul 20, 2007·Taiwanese Journal of Obstetrics & Gynecology·Hsun-Han TangKuo-Feng Huang
Dec 14, 2004·Reproductive Biomedicine Online·J C Emperaire, R G Edwards
Jun 3, 2008·Fertility and Sterility·Ri-Cheng ChianSeang Lin Tan
Apr 10, 2007·Fertility and Sterility·Mohammed Al-SunaidiSeang Lin Tan
Mar 6, 2007·Fertility and Sterility·Hananel HolzerSeang Lin Tan
Mar 8, 2014·CA: a Cancer Journal for Clinicians·Jonathan D KortLynn M Westphal
Jan 10, 2002·The American Journal of Emergency Medicine·Christopher W Garrett, Theodore J Gaeta
Mar 7, 2006·Molecular and Cellular Endocrinology·E Vrtacnik BokalD Rozman
Sep 25, 2014·The Linacre Quarterly·Derek M Doroski
Sep 1, 2005·Gynécologie, obstétrique & fertilité·P MervielA Nasreddine
May 12, 2004·Radiologic Clinics of North America·Emily M WebbLeslie M Scoutt
Sep 25, 2004·Critical Care Clinics·Jaime F AvecillasAlejandro C Arroliga
Jun 5, 2016·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Michael H DahanSeang L Tan
Jan 19, 2015·Reproductive Biomedicine Online·Noora KaartinenHelena Tinkanen
Apr 26, 2012·Reproductive Biology and Endocrinology : RB&E·Klaus Fiedler, Diego Ezcurra
Sep 2, 1999·Human Reproduction·Y AbramovJ G Schenker
Jun 12, 2004·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Canan Togay-IsikayAytaç Yigit
Apr 9, 2011·British Journal of Hospital Medicine·Ao LiangfeiYang Jing
Jul 20, 2007·The Cochrane Database of Systematic Reviews·A D'Angelo, N Amso
Feb 7, 2001·The Australian & New Zealand Journal of Obstetrics & Gynaecology·P W HowatM D Humphrey
Oct 17, 2008·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Andrea BartkovaPetr Kanovsky
Aug 1, 1997·British Journal of Obstetrics and Gynaecology·E C Edi-Osagie, R E Hopkins
Oct 1, 1996·British Journal of Obstetrics and Gynaecology·F E Okonofua
Jun 1, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Talha Al-ShawafGedis Grudzinskas
Feb 24, 2010·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Paula Kuivasaari-PirinenSeppo Heinonen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.